ArticleRadiology case reports2026
Sustained monomorphic ventricular tachycardia as the first manifestation of probable cardiac sarcoidosis: A case report.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiac sarcoidosis is an inflammatory heart disease that can cause conduction block, ventricular arrhythmias, and cardiomyopathy. Sustained monomorphic ventricular tachycardia is a high-risk presentation and may be the first sign of disease. A 69-year-old man with paroxysmal atrial fibrillation and chronic diastolic heart failure presented with palpitations, dizziness, and shortness of breath after a physical-therapy session. In the emergency department, he was found to be in atrial fibrillation with rapid ventricular response and frequent sustained runs of monomorphic ventricular tachycardia at rates >200 beats/min. Intravenous amiodarone was started. Echocardiography showed mildly reduced left ventricular ejection fraction (46%) and apical hypokinesis. Coronary angiography revealed only minimal nonobstructive coronary artery disease. Cardiac magnetic resonance imaging demonstrated mildly reduced left ventricular function (45%) and a nonischemic pattern of late gadolinium enhancement in the basal anteroseptal, basal inferoseptal, mid-inferoseptal, and inferior segments, highly suggestive of cardiac sarcoidosis. Endomyocardial biopsy was not pursued because of its low sensitivity and invasive risk, and the patient met contemporary criteria for "probable" cardiac sarcoidosis based on imaging and clinical findings. A targeted evaluation for extracardiac disease and infiltrative mimics was unremarkable. Further testing, including positron emission tomography, was planned as outpatient testing. He underwent implantation of a single-chamber implantable cardioverter-defibrillator for secondary prevention and was discharged in stable condition. This case highlights cardiac sarcoidosis as an important cause of sustained ventricular tachycardia in patients with non-ischemic scar on cardiac magnetic resonance and minimal coronary disease. Modern guidelines allow a working diagnosis without biopsy, relying instead on cardiac magnetic resonance and positron emission tomography.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.